To see the other types of publications on this topic, follow the link: Molecular virology.

Journal articles on the topic 'Molecular virology'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Molecular virology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Doorbar, John. "Molecular virology." Trends in Microbiology 3, no. 2 (February 1995): 80. http://dx.doi.org/10.1016/s0966-842x(00)88883-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stephenson, Iain. "Influenza: Molecular Virology." Expert Review of Vaccines 9, no. 7 (July 2010): 719–20. http://dx.doi.org/10.1586/erv.10.71.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Whitley, Richard. "Alphaherpesviruses: Molecular Virology." Antiviral Therapy 17, no. 2 (2011): 409. http://dx.doi.org/10.3851/imp1929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bangham, C. R. M. "Practical Molecular Virology." Journal of Medical Genetics 30, no. 6 (June 1, 1993): 536. http://dx.doi.org/10.1136/jmg.30.6.536-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Netesov, S. V., and N. A. Markovich. "Introduction to molecular virology." Russian Journal of Genetics: Applied Research 4, no. 4 (July 2014): 325–39. http://dx.doi.org/10.1134/s2079059714040078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cane, P. "Molecular Virology, 2nd edn." Journal of Antimicrobial Chemotherapy 43, no. 1 (January 1, 1999): 168. http://dx.doi.org/10.1093/jac/43.1.168.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vernet, Guy. "Molecular diagnostics in virology." Journal of Clinical Virology 31, no. 4 (December 2004): 239–47. http://dx.doi.org/10.1016/j.jcv.2004.06.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lachman, Robin. "Molecular virology in brief." Molecular Medicine Today 5, no. 2 (February 1999): 55. http://dx.doi.org/10.1016/s1357-4310(98)01412-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Elliott, Richard M. "Molecular virology made simple." Trends in Microbiology 2, no. 8 (August 1994): 300–301. http://dx.doi.org/10.1016/0966-842x(94)90011-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brierley, Ian. "Principles of molecular virology." Trends in Biochemical Sciences 19, no. 10 (October 1994): 433. http://dx.doi.org/10.1016/0968-0004(94)90095-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Henderson, Lee A. "Laboratory of Molecular Virology." Guthrie Journal 63, no. 2 (April 1994): 57–58. http://dx.doi.org/10.3138/guthrie.63.2.057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Schwyzer, Martin, and Mathias Ackermann. "Molecular virology of ruminant herpesviruses." Veterinary Microbiology 53, no. 1-2 (November 1996): 17–29. http://dx.doi.org/10.1016/s0378-1135(96)01231-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Mossman, Karen. "Methods related to molecular virology." Methods 55, no. 2 (October 2011): 107–8. http://dx.doi.org/10.1016/j.ymeth.2011.10.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Mossman, Karen. "Methods related to molecular virology." Methods 90 (November 2015): 1–2. http://dx.doi.org/10.1016/j.ymeth.2015.11.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Carter, Michael J. "Molecular virology: a practical approach." Trends in Microbiology 2, no. 5 (May 1994): 183. http://dx.doi.org/10.1016/0966-842x(94)90670-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Pesavento, Patricia A., Kyeong-Ok Chang, and John S. L. Parker. "Molecular Virology of Feline Calicivirus." Veterinary Clinics of North America: Small Animal Practice 38, no. 4 (July 2008): 775–86. http://dx.doi.org/10.1016/j.cvsm.2008.03.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Hartenian, Ella, Divya Nandakumar, Azra Lari, Michael Ly, Jessica M. Tucker, and Britt A. Glaunsinger. "The molecular virology of coronaviruses." Journal of Biological Chemistry 295, no. 37 (July 13, 2020): 12910–34. http://dx.doi.org/10.1074/jbc.rev120.013930.

Full text
Abstract:
Few human pathogens have been the focus of as much concentrated worldwide attention as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID-19. Its emergence into the human population and ensuing pandemic came on the heels of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), two other highly pathogenic coronavirus spillovers, which collectively have reshaped our view of a virus family previously associated primarily with the common cold. It has placed intense pressure on the collective scientific community to develop therapeutics and vaccines, whose engineering relies on a detailed understanding of coronavirus biology. Here, we present the molecular virology of coronavirus infection, including its entry into cells, its remarkably sophisticated gene expression and replication mechanisms, its extensive remodeling of the intracellular environment, and its multifaceted immune evasion strategies. We highlight aspects of the viral life cycle that may be amenable to antiviral targeting as well as key features of its biology that await discovery.
APA, Harvard, Vancouver, ISO, and other styles
18

Clementi, M., S. Menzo, A. Manzin, and P. Bagnarelli. "Quantitative molecular methods in virology." Archives of Virology 140, no. 9 (September 1995): 1523–39. http://dx.doi.org/10.1007/bf01322527.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Josko, Deborah. "Molecular Virology in the Clinical Laboratory." American Society for Clinical Laboratory Science 23, no. 4 (October 2010): 231–36. http://dx.doi.org/10.29074/ascls.23.4.231.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Preiser, W. "Quantitative molecular virology in patient management." Journal of Clinical Pathology 53, no. 1 (January 1, 2000): 76–83. http://dx.doi.org/10.1136/jcp.53.1.76.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Lever, Andrew. "Principles of molecular virology (2nd edn)." Trends in Genetics 13, no. 7 (July 1997): 290. http://dx.doi.org/10.1016/s0168-9525(97)88216-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Ahmad, Imran, R. Prasida Holla, and Shahid Jameel. "Molecular virology of hepatitis E virus." Virus Research 161, no. 1 (October 2011): 47–58. http://dx.doi.org/10.1016/j.virusres.2011.02.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Clarke, B. "Molecular virology of hepatitis C virus." Journal of General Virology 78, no. 10 (October 1, 1997): 2397–410. http://dx.doi.org/10.1099/0022-1317-78-10-2397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Locarnini, Stephen. "Molecular Virology of Hepatitis B Virus." Seminars in Liver Disease 24 (February 2004): 3–10. http://dx.doi.org/10.1055/s-2004-828672.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Ahmad, Zulfazal, R. Holla, Imran Ahmad, and Shahid Jameel. "Molecular Virology of Hepatitis E Virus." Seminars in Liver Disease 33, no. 01 (April 5, 2013): 003–14. http://dx.doi.org/10.1055/s-0033-1338110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Read, S. J. "Molecular techniques for clinical diagnostic virology." Journal of Clinical Pathology 53, no. 7 (July 1, 2000): 502–6. http://dx.doi.org/10.1136/jcp.53.7.502.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Bornkamm, Georg W., and Wolfgang Hammerschmidt. "Molecular virology of Epstein–Barr virus." Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 356, no. 1408 (April 29, 2001): 437–59. http://dx.doi.org/10.1098/rstb.2000.0781.

Full text
Abstract:
Epstein–Barr virus (EBV) interacts with its host in three distinct ways in a highly regulated fashion: (i) EBV infects human B lymphocytes and induces proliferation of the infected cells, (ii) it enters into a latent phase in vivo that follows the proliferative phase, and (iii) it can be reactivated giving rise to the production of infectious progeny for reinfection of cells of the same type or transmission of the virus to another individual. In healthy people, these processes take place simultaneously in different anatomical and functional compartments and are linked to each other in a highly dynamic steady–state equilibrium. The development of a genetic system has paved the way for the dissection of those processes at a molecular level that can be studied in vitro , i.e. B–cell immortalization and the lytic cycle leading to production of infectious progeny. Polymerase chain reaction analyses coupled to fluorescent–activated cell sorting has on the other hand allowed a descriptive analysis of the virus–host interaction in peripheral blood cells as well as in tonsillar B cells in vivo . This paper is aimed at compiling our present knowledge on the process of B–cell immortalization in vitro as well as in vivo latency, and attempts to integrate this knowledge into the framework of the viral life cycle in vivo .
APA, Harvard, Vancouver, ISO, and other styles
28

Panda, Subrat K., and Satya P. K. Varma. "Hepatitis E: Molecular Virology and Pathogenesis." Journal of Clinical and Experimental Hepatology 3, no. 2 (June 2013): 114–24. http://dx.doi.org/10.1016/j.jceh.2013.05.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Major, M. E., and S. M. Feinstone. "The molecular virology of hepatitis C." Hepatology 25, no. 6 (June 1997): 1527–38. http://dx.doi.org/10.1002/hep.510250637.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Kelley, Violet A., and Angela M. Caliendo. "Successful Testing Protocols in Virology." Clinical Chemistry 47, no. 8 (August 1, 2001): 1559–62. http://dx.doi.org/10.1093/clinchem/47.8.1559.

Full text
Abstract:
Abstract Molecular methods have had a significant impact on the diagnosis of viral infections because of their superior sensitivity and rapid turnaround time compared with conventional diagnostic methods. These characteristics have allowed molecular tests to play a central role in the use of testing protocols for managing viral infections. Several examples of such protocols are reviewed in this report, including the use of molecular testing for early disease detection to improve overall disease management and to direct antiviral therapy.
APA, Harvard, Vancouver, ISO, and other styles
31

Bremer, Corinna, and Dieter Glebe. "The Molecular Virology of Hepatitis B Virus." Seminars in Liver Disease 33, no. 02 (June 8, 2013): 103–12. http://dx.doi.org/10.1055/s-0033-1345717.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Rawlinson, William. "Viral illness, applied molecular virology and antivirals." Pathology 41 (January 2009): 45. http://dx.doi.org/10.1097/01268031-200941001-00089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Chinen, Javier, and William T. Shearer. "Molecular virology and immunology of HIV infection." Journal of Allergy and Clinical Immunology 110, no. 2 (August 2002): 189–98. http://dx.doi.org/10.1067/mai.2002.126226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Hillis, D. M. "Evolutionary Virology: Molecular Basis of Virus Evolution." Science 273, no. 5279 (August 30, 1996): 1179–80. http://dx.doi.org/10.1126/science.273.5279.1179.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

De Francesco, Raffaele. "Molecular virology of the hepatitis C virus." Journal of Hepatology 31 (January 1999): 47–53. http://dx.doi.org/10.1016/s0168-8278(99)80374-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Moradpour, Darius, Volker Brass, Rainer Gosert, Benno Wölk, and Hubert E. Blum. "Hepatitis C: molecular virology and antiviral targets." Trends in Molecular Medicine 8, no. 10 (October 2002): 476–82. http://dx.doi.org/10.1016/s1471-4914(02)02395-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Lai-Hung Wong, Grace, and Henry Lik-Yuen Chan. "Molecular virology in chronic hepatitis B: genotypes." British Journal of Hospital Medicine 66, no. 1 (January 2005): 13–16. http://dx.doi.org/10.12968/hmed.2005.66.1.17529.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Scagnolari, Carolina, Ombretta Turriziani, Katia Monteleone, Alessandra Pierangeli, and Guido Antonelli. "Consolidation of molecular testing in clinical virology." Expert Review of Anti-infective Therapy 15, no. 4 (December 24, 2016): 387–400. http://dx.doi.org/10.1080/14787210.2017.1271711.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Moore, Patrick S., and Yuan Chang. "Molecular virology of Kaposi's sarcoma–associated herpesvirus." Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 356, no. 1408 (April 29, 2001): 499–516. http://dx.doi.org/10.1098/rstb.2000.0777.

Full text
Abstract:
Kaposi's sarcoma–associated herpesvirus (KSHV), the most recently discovered human tumour virus, is the causative agent of Kaposi's sarcoma, primary effusion lymphoma and some forms of Castleman's disease. KSHV is a rhadinovirus, and like other rhadinoviruses, it has an extensive array of regulatory genes obtained from the host cell genome. These pirated KSHV proteins include homologues to cellular CD21, three different β–chemokines, IL–6, BCL–2, several different interferon regulatory factor homologues, Fas–ligand ICE inhibitory protein (FLIP), cyclin D and a G–protein–coupled receptor, as well as DNA synthetic enzymes including thymidylate synthase, dihydrofolate reductase, DNA polymerase, thymidine kinase and ribonucleotide reductases. Despite marked differences between KSHV and Epstein–Barr virus, both viruses target many of the same cellular pathways, but use different strategies to achieve the same effects. KSHV proteins have been identified which inhibit cell–cycle regulation checkpoints, apoptosis control mechanisms and the immune response regulatory machinery. Inhibition of these cellular regulatory networks appears to be a defensive means of allowing the virus to escape from innate antiviral immune responses. However, due to the overlapping nature of innate immune and tumour–suppressor pathways, inhibition of these regulatory networks can lead to unregulated cell proliferation and may contribute to virus–induced tumorigenesis.
APA, Harvard, Vancouver, ISO, and other styles
40

LAU, J. "Molecular virology and pathogenesis of hepatitis B." Lancet 342, no. 8883 (November 1993): 1311–40. http://dx.doi.org/10.1016/0140-6736(93)92249-s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Kruglov, I. V. "ON BIOCHEMISTRY, «MOLECULAR BIOLOGY», VIROLOGY AND EPIDEMIOLOGY." International Journal of Applied and Fundamental Research (Международный журнал прикладных и фундаментальных исследований), no. 3 2024 (2024): 5–10. http://dx.doi.org/10.17513/mjpfi.13614.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Wickner, Reed B. "Yeast virology." FASEB Journal 3, no. 11 (September 1989): 2257–65. http://dx.doi.org/10.1096/fasebj.3.11.2550303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

NAGASAKI, Keizo, and Yuji TOMARU. "Recent progress in protist virology - molecular ecology, taxomony, molecular evolution." Uirusu 59, no. 1 (2009): 31–36. http://dx.doi.org/10.2222/jsv.59.31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Madeley, Dick. "Molecular Virology Techniques, Part A (Methods in Molecular Genetics series)." Trends in Microbiology 3, no. 9 (September 1995): 366. http://dx.doi.org/10.1016/s0966-842x(00)88977-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

McLeish, Tom, Peter Stockley, and Reidun Twarock. "Mathematical Virology." Journal of Theoretical Medicine 6, no. 2 (2005): 67–68. http://dx.doi.org/10.1080/10273660500150115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Strauss, Ellen G., and James H. Strauss. "Fundamental virology." Cell 47, no. 6 (December 1986): 841–42. http://dx.doi.org/10.1016/0092-8674(86)90796-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Zaltlin, Milton. "Plant virology." Cell 67, no. 6 (December 1991): 1039. http://dx.doi.org/10.1016/0092-8674(91)90281-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Škorić, Dijana, Silvija Černi, Mirna Ćurković-Perica, Marin Ježić, Mladen Krajačić, and Martina Šeruga Musić. "Legacy of Plant Virology in Croatia—From Virus Identification to Molecular Epidemiology, Evolution, Genomics and Beyond." Viruses 13, no. 12 (November 23, 2021): 2339. http://dx.doi.org/10.3390/v13122339.

Full text
Abstract:
This paper showcases the development of plant virology in Croatia at the University of Zagreb, Faculty of Science, from its beginning in the 1950s until today, more than 70 years later. The main achievements of the previous and current group members are highlighted according to various research topics and fields. Expectedly, some of those accomplishments remained within the field of plant virology, but others make part of a much-extended research spectrum exploring subviral pathogens, prokaryotic plant pathogens, fungi and their viruses, as well as their interactions within ecosystems. Thus, the legacy of plant virology in Croatia continues to contribute to the state of the art of microbiology far beyond virology. Research problems pertinent for directing the future research endeavors are also proposed in this review.
APA, Harvard, Vancouver, ISO, and other styles
49

Zuo, Kunlan, Wanying Gao, Zongzhen Wu, Lei Zhang, Jiafeng Wang, Xuefan Yuan, Chun Li, Qiangyu Xiang, Lu Lu, and Huan Liu. "Evolution of Virology: Science History through Milestones and Technological Advancements." Viruses 16, no. 3 (February 28, 2024): 374. http://dx.doi.org/10.3390/v16030374.

Full text
Abstract:
The history of virology, which is marked by transformative breakthroughs, spans microbiology, biochemistry, genetics, and molecular biology. From the development of Jenner’s smallpox vaccine in 1796 to 20th-century innovations such as ultrafiltration and electron microscopy, the field of virology has undergone significant development. In 1898, Beijerinck laid the conceptual foundation for virology, marking a pivotal moment in the evolution of the discipline. Advancements in influenza A virus research in 1933 by Richard Shope furthered our understanding of respiratory pathogens. Additionally, in 1935, Stanley’s determination of viruses as solid particles provided substantial progress in the field of virology. Key milestones include elucidation of reverse transcriptase by Baltimore and Temin in 1970, late 20th-century revelations linking viruses and cancer, and the discovery of HIV by Sinoussi, Montagnier, and Gallo in 1983, which has since shaped AIDS research. In the 21st century, breakthroughs such as gene technology, mRNA vaccines, and phage display tools were achieved in virology, demonstrating its potential for integration with molecular biology. The achievements of COVID-19 vaccines highlight the adaptability of virology to global health.
APA, Harvard, Vancouver, ISO, and other styles
50

Cann, Alan J. "Virology Labfax." Molecular Biotechnology 1, no. 3 (June 1994): 313. http://dx.doi.org/10.1007/bf02921700.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography